|
gptkbp:instanceOf
|
gptkb:parasitologist
gptkb:disease
|
|
gptkbp:affects
|
gptkb:skin
humans
mammals
|
|
gptkbp:cause
|
psychological distress
social stigma
|
|
gptkbp:causedBy
|
gptkb:Leishmania_braziliensis
gptkb:Leishmania_major
gptkb:Leishmania_mexicana
gptkb:Leishmania_parasite
gptkb:Leishmania_tropica
|
|
gptkbp:complication
|
disfigurement
secondary infection
|
|
gptkbp:diagnosedBy
|
gptkb:culture
PCR
microscopy
serology
|
|
gptkbp:firstDescribed
|
gptkb:19th_century
|
|
gptkbp:form
|
gptkb:mucocutaneous_leishmaniasis
diffuse cutaneous leishmaniasis
localized cutaneous leishmaniasis
|
|
gptkbp:ICD-10_code
|
B55.1
|
|
gptkbp:mortalityRate
|
low
|
|
gptkbp:notifiableDisease
|
true
|
|
gptkbp:prevalence
|
gptkb:Africa
gptkb:Asia
gptkb:Central_America
gptkb:Middle_East
gptkb:South_America
subtropical regions
tropical regions
|
|
gptkbp:prevention
|
gptkb:entomologist
gptkb:personal_protective_equipment
vector control
|
|
gptkbp:relatedTo
|
gptkb:mucocutaneous_leishmaniasis
gptkb:visceral_leishmaniasis
|
|
gptkbp:symptom
|
skin ulcers
scarring
skin lesions
|
|
gptkbp:transmittedBy
|
gptkb:sandfly
|
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:miltefosine
gptkb:paromomycin
antimonial drugs
|
|
gptkbp:vectorFor
|
gptkb:Phlebotomine_sandflies
|
|
gptkbp:zoonotic
|
true
|
|
gptkbp:bfsParent
|
gptkb:Leishmania_parasites
|
|
gptkbp:bfsLayer
|
7
|
|
http://www.w3.org/2000/01/rdf-schema#label
|
Cutaneous leishmaniasis
|